Back to search results

CAR-T Followed by Bispecific Antibodies

Abroad (travel likely)RecruitingPHASE2

Conditions

Large B-cell Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Katie Bourret, RN) · kbourret@unmc.edu · 402-552-9601
    Contact: Study coordinator (Linda Chee, CRC) · linda.chee@unmc.edu
    Robert Gregory Bociek, MD (Sub-investigator)
    Christopher D'Angelo, MD (Sub-investigator)
    Julie Vose, MD (Sub-investigator)
    Snegha Ananth, MD (Sub-investigator)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Rachel Lundberg, PA-C) · Rachel.Lundberg@Pennmedicine.upenn.edu · 215-615-5858
    Contact: Study coordinator (Kaitlin Kennard, RN) · Kaitlin.Kennard@pennmedicine.upenn.edu · 215-615-5858
    Contact: Principal Investigator (Stephen J. Schuster, MD)
    Elise A. Chong, MD (Sub-investigator)
    Jakub Svoboda, MD (Sub-investigator)
Study leads

  • Stephen J. Schuster, MD

    Principal Investigator

    University of Pennsylvania

View source on ClinicalTrials.gov(opens in a new tab)